SALT LAKE CITY--(BUSINESS WIRE)--Foldax®, Inc. today announced that the Drugs Controller General of India (DCGI), India’s regulatory body for medical devices, has approved initiation of a clinical ...
SALT LAKE CITY--(BUSINESS WIRE)--Foldax®, Inc. today announced the presentation of results from the first animal study of its transcatheter valve from the TRIA™ biopolymer heart valve portfolio this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results